Synthetic ‘kill switch’ could fast track new immunotherapies, turning bacterial armies against cancer tumours, study shows.

For decades, scientists have explored the potential of bacteria in fighting cancer, but safety and efficacy barriers have ...

coli bacteria produces an enzyme which breaks the contents of their cells down into nutrients after death. The dead bacteria are therefore offering a banquet of nutrients to the cells that were ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.

Gut bacteria are to blame for the failure of ... uncover novel therapies capable of helping the immune system kill cancer cells." Ovarian cancer kills more than 10,000 American women every year ...

Traditionally, radiation, chemotherapy, and surgery have been the most common ways to remove and destroy malignant cells.

Researchers have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors. According to preclinical results, the approach combined the benefits of ...